Sign in
4

Changes in Ownership

AbCellera Biologics Inc. Filed Acc 0001209191-23-032484

Chief Financial Officer bought 14,500 shares at $6.85 ($99,325)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Booth Andrew Chief Financial Officer 2023-05-26 Purchase +14,500 $6.85 $99,325 153,000 D
Open-market purchases · 14,500 sh · avg $6.85 · $99,325
Loading xslF345X04/doc4.xml…